Search - tctmd.com

Displaying 481 - 500 of 7326

Sort: Relevancy | Date

Presentation NY Valves 2025

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Presenter: Philipp von Stein

June 25, 2025

Presentation NY Valves 2025

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Presenter: Mark J. Ricciardi

June 25, 2025

Presentation NY Valves 2025

Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial

Presenter: Suzanne V. Arnold

June 25, 2025

Presentation NY Valves 2025

Early Outcomes of Real-World TTVR (Evoque)

Presenter: Fabien Praz

June 25, 2025

Presentation NY Valves 2025

Clinical and Economic Outcomes by Stage of Cardiac Damage and Clinical Presentation at Aortic Valve Replacemen

Presenter: Philippe Genereux

June 25, 2025

Presentation NY Valves 2025

Structuralist Viewpoint

Presenter: Ralph Stephan von Bardeleben

June 25, 2025

Presentation NY Valves 2025

Surgical Viewpoint

Presenter: Michael A. Borger

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Nino Mihatov

June 25, 2025

Presentation NY Valves 2025

The Imager Perspective: Can Imaging Insights Determine Optimal Treatment Strategy?

Presenter: Konstantinos P. Koulogiannis

June 25, 2025

Presentation NY Valves 2025

The Structuralists Perspective: Why Not Try Mitral TEER First? (Surgery Can Always Be a Later Option)

Presenter: Sam Dawkins

June 25, 2025

Presentation NY Valves 2025

The Mitral Surgeon’s Perspective: High Risk Surgery is Better than Sub-Optimal Mitral TEER!

Presenter: Arnar Geirsson

June 25, 2025

Presentation NY Valves 2025

Case Presentation: Primary MR in a High-Surgical Risk Patient with “Yellow-Zone” Anatomy

Presenter: Nino Mihatov

June 25, 2025

Presentation Fellows 2025

Peripheral Case Potpourri: Head to Toe (Includes Carotid, Renal, and CLI)

Presenter: Sonal Pruthi

May 18, 2025

Presentation Fellows 2025

Evidence That Matters: Learning the Clinical Data Behind Ultrasound RDN

Presenter: Ajay J. Kirtane

May 17, 2025

Presentation ACC 2025

The MIGHTy-Heart Randomized Clinical Trial

Presenter: Ruth Masterson Creber

March 30, 2025

Presentation ACC 2025

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Presenter: Marc P. Bonaca

March 29, 2025

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Presenter: Keyvan Karkouti

March 29, 2025

Presentation CTO 2025

Leveraging Wire-free Physiology in the Assessment of Collaterals

Presenter: Karim Al-Azizi

March 01, 2025

Advertisement

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial

Early Outcomes of Real-World TTVR (Evoque)

Clinical and Economic Outcomes by Stage of Cardiac Damage and Clinical Presentation at Aortic Valve Replacemen

Structuralist Viewpoint

Surgical Viewpoint

Case Resolution

The Imager Perspective: Can Imaging Insights Determine Optimal Treatment Strategy?

The Structuralists Perspective: Why Not Try Mitral TEER First? (Surgery Can Always Be a Later Option)

The Mitral Surgeon’s Perspective: High Risk Surgery is Better than Sub-Optimal Mitral TEER!

Case Presentation: Primary MR in a High-Surgical Risk Patient with “Yellow-Zone” Anatomy

Peripheral Case Potpourri: Head to Toe (Includes Carotid, Renal, and CLI)

Evidence That Matters: Learning the Clinical Data Behind Ultrasound RDN

The MIGHTy-Heart Randomized Clinical Trial

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Leveraging Wire-free Physiology in the Assessment of Collaterals

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content